A Phase II study of Neoadjuvant chemotherapy in Tri-weekly nab-Paclitaxel followed by FEC with Operable HER2 Negative breast cancer
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- 11 May 2016 Status changed from active, no longer recruiting to completed according to results presented at the Official 10th European Breast Cancer Conference .
- 05 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 07 Jun 2012 New trial record